Supplement use during an intergroup clinical trial for breast cancer (S0221).
about
Micronutrients in Oncological InterventionChanges in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study.Dietary supplement use among participants of a databank and biorepository at a comprehensive cancer centreMultivitamin and mineral use and breast cancer mortality in older women with invasive breast cancer in the women's health initiative.Dietary Supplements Commonly Used by Cancer Survivors: Are There Any Benefits?Dietary supplement use among cancer survivors of the NutriNet-Santé cohort study.Phytotherapy and Nutritional Supplements on Breast CancerA stakeholder-informed randomized, controlled comparative effectiveness study of an order prescribing intervention to improve colony stimulating factor use for cancer patients receiving myelosuppressive chemotherapy: the TrACER study.Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study.
P2860
Q26764839-7678AEAC-B3F3-4D5F-8EED-D0C64FD19CE3Q33762649-27F9EED0-75D4-4D6F-9951-51D39FB08987Q35646304-5261E094-872B-42A8-857E-4426E182841FQ37516130-9D6D3377-DE16-4102-A6CC-8D72FF90C676Q38622264-EC649425-9D86-4DBF-8E8C-C3AC9501E2AAQ41135449-3545FBDD-54BB-4131-AF33-608B4B7CCC16Q41463405-49B94AFC-4197-4DF6-B44A-5ECCC53DE741Q47327831-7C71D63A-60C8-4D3A-BB2D-764639E63EBAQ53078776-D22E19E8-C724-43D9-A596-8D7C891EF158
P2860
Supplement use during an intergroup clinical trial for breast cancer (S0221).
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Supplement use during an intergroup clinical trial for breast cancer (S0221).
@ast
Supplement use during an intergroup clinical trial for breast cancer (S0221).
@en
type
label
Supplement use during an intergroup clinical trial for breast cancer (S0221).
@ast
Supplement use during an intergroup clinical trial for breast cancer (S0221).
@en
prefLabel
Supplement use during an intergroup clinical trial for breast cancer (S0221).
@ast
Supplement use during an intergroup clinical trial for breast cancer (S0221).
@en
P2093
P2860
P50
P1476
Supplement use during an intergroup clinical trial for breast cancer (S0221).
@en
P2093
Chi-Chen Hong
G Thomas Budd
Gabriel N Hortobagyi
Gary R Zirpoli
Gregory Ciupak
Halle C F Moore
James Stewart
Joseph M Unger
Julie R Gralow
Kathy S Albain
P2860
P2888
P304
P356
10.1007/S10549-012-2400-2
P407
P577
2013-01-10T00:00:00Z